Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 4Recruiting 3Active not recruiting 3Terminated 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 2678Pancreatic Neoplasms 1470Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1127Rectal Neoplasms 980Esophageal Neoplasms 728Neoplasms 559Liver Neoplasms 533Breast Neoplasms 473Neoplasm Metastasis 373Lung Neoplasms 325Carcinoma, Non-Small-Cell Lung 292Gastrointestinal Neoplasms 277Ovarian Neoplasms 258Prostatic Neoplasms 229Cholangiocarcinoma 221Head and Neck Neoplasms 180Gastrointestinal Stromal Tumors 176Melanoma 165Esophageal Squamous Cell Carcinoma 164Barrett Esophagus 156Uterine Cervical Neoplasms 151Biliary Tract Neoplasms 149Adenocarcinoma Of Esophagus 148Gallbladder Neoplasms 136Carcinoma, Renal Cell 134Urinary Bladder Neoplasms 132Sarcoma 131Anus Neoplasms 124

Interventions

pembrolizumab 2Nivolumab 2vicriviroc 1relatlimab 1copanlisib 1binimetinib 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Spinocerebellar Degenerations × Gastrointestinal × Clear all
NCT03711058 2025-09-16

Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
48 enrolled 16 charts
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Spinocerebellar Degenerations

NCT03642067 2025-06-15

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
59 enrolled 11 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Spinocerebellar Degenerations, Colorectal Neoplasms

NCT03374254 2024-11-21

KEYNOTE-651

Merck Sharp & Dohme LLC

Phase 1 Completed
116 enrolled 18 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Spinocerebellar Degenerations, Colorectal Neoplasms

NCT03631407 2024-11-21

MK-7690-046

Merck Sharp & Dohme LLC

Phase 2 Completed
41 enrolled 20 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡